BusulfanTransplantation ConditioningMyeloablative AgonistsBone Marrow TransplantationCyclophosphamideAntineoplastic Agents, AlkylatingEarly Detection of CancerHepatic Veno-Occlusive DiseaseTransplantation, HomologousAntineoplastic Combined Chemotherapy ProtocolsSurvival AnalysisVidarabineAlkylating AgentsWhole-Body IrradiationGraft vs Host DiseaseProstatic NeoplasmsOvarian NeoplasmsCombined Modality TherapyBreast NeoplasmsLung NeoplasmsTransplantation, AutologousNeoplasmsStomach NeoplasmsSurvival RateColonic NeoplasmsDisease-Free SurvivalRetrospective StudiesNeoplasm MetastasisNeoplasm InvasivenessFollow-Up StudiesImmunosuppressive AgentsThiotepaAntineoplastic AgentsPancreatic NeoplasmsMelphalanPrognosisGene Expression Regulation, NeoplasticMice, NudeCancer VaccinesLeukemiaHematologic NeoplasmsDose-Response Relationship, DrugNeoplasm ProteinsGraft SurvivalProspective StudiesUterine Cervical NeoplasmsTreatment OutcomeDrug MonitoringGenetic Predisposition to DiseaseGlutathione TransferaseCell Line, TumorSulfonic AcidsAge FactorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveDrug Resistance, NeoplasmCarcinomaUrinary Bladder NeoplasmsCarcinoma, Non-Small-Cell LungCarcinoma, Squamous CellNational Cancer Institute (U.S.)Disease ProgressionRiskAdministration, OralSpermatogoniaMyelodysplastic SyndromesReverse Transcriptase Polymerase Chain ReactionColorectal NeoplasmsTransplantation ChimeraHistocompatibilityLeukemia, Myeloid, AcuteOogoniaDrug EvaluationReceptors, EstrogenLeukemia, MyeloidGene Expression ProfilingTransplantation, HeterologousRegistriesXenograft Model Antitumor AssaysTumor Markers, BiologicalDrug Administration ScheduleAntilymphocyte SerumMutationNeoplasm StagingRNA, MessengerSurvivorsReceptor, erbB-2Pharmaceutical SolutionsRisk AssessmentUnited StatesEtoposideRectal NeoplasmsNeoplasm Recurrence, LocalMultivariate AnalysisActuarial AnalysisNeoplasm TransplantationSeminiferous TubulesGenotypeRisk FactorsProstate-Specific AntigenMetabolic Clearance Rate